Friday, June 12, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 180 of 1,261
  1. US 11712427

    Method for increasing serum adiponectin for treatment and reduction of the risk of cardiovascular, vascular, and related diseases

    FIRST FRUITS BUSINESS MINISTRY, LLC · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  2. US 11714089

    Combination of markers for diagnosing cancer

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  3. US 11712418

    Chemoembolization agents

    The Regents of the University of California · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  4. US 11712461

    Long-acting polypeptide composition for treating atrial fibrillation and its application

    The First Affiliated Hospital of Xi'an Jiaotong University · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  5. US 11713446

    Processes for generating TIL products enriched for tumor antigen-specific T-cells

    Iovance Biotherapeutics, Inc. · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  6. US 11712460

    Methods of treating chronic disorders with complement inhibitors

    Apellis Pharmaceuticals, Inc. · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  7. US 11713462

    Modulation of GYS1 expression

    Ionis Pharmaceuticals, Inc. · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  8. US 11713295

    Psychotropic agents and uses thereof

    LB PHARMACEUTICALS INC. · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  9. WO 2023141408

    BÊTA-HYDROXY BÊTA-MÉTHYLBUTYRATE ET FLAVONOÏDE D'AGRUME POUR FAVORISER LA RÉGÉNÉRATION MUSCULAIRE

    ABBOTT LAB [US] · Granted Jul 27, 2023 · Expires Jul 22, 2043

    granted
  10. US 11707506

    Use of a VEGF antagonist to treat angiogenic eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  11. US 11707447

    C4-carbonothioate-substituted tryptamine derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  12. US 11707503

    Modulators of complement activity

    RA PHARMACEUTICALS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  13. US 11707346

    Dental mill blank and method for producing same

    KURARAY NORITAKE DENTAL INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  14. US 11707459

    Method for treating nervous system injuries using boldine and analogs thereof

    United States Government as represented by the Department of Veterans Affairs · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  15. US 11708407

    Antigen binding molecule formats

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  16. US 11708416

    Methods of treating severe insulin resistance by interfering with glucagon receptor signaling

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  17. US 11708400

    T-cell modulatory multimeric polypeptides and methods of use thereof

    Cue Biopharma, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  18. US 11707434

    Method for preparing organic solvent-free lyophilized cyclophosphamide

    KOREA UNITED PHARM. INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  19. US 11707454

    Topical roflumilast formulation having antifungal properties

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  20. US 11707535

    Method and composition for treating neuropathic pain

    The Regents of the University of California · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  21. US 11708332

    Human plasma kallikrein inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  22. US 11708347

    Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  23. US 11708329

    Inhibitors of the WNT/beta-catenin pathway

    The Regents of the University of California · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  24. US 11708364

    Azaindole derivatives and their use as ERK kinase inhibitors

    AGV Discovery · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.